Difference between revisions of "Actinium Ac 225 lintuzumab (Actimab-A)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Investigational" to "Category:Investigational drugs") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "") |
||
| Line 8: | Line 8: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| − | + | ||
[[Category:Radiotherapy medications]] | [[Category:Radiotherapy medications]] | ||
[[Category:Anti-CD33 antibodies]] | [[Category:Anti-CD33 antibodies]] | ||
Revision as of 19:43, 27 February 2020
Mechanism of action
Monoclonal antibody directed against CD33 with a radioactive agent attached.